India's first indigenous mRNA vaccine candidate has received approval from the DGCI to initiate Phase I/II human clinical trial. The novel mRNA vaccine candidate, HGCO19 has been developed by which of the following?
India's first indigenous mRNA vaccine candidate has received approval from the DGCI to initiate Phase I/II human clinical trial. The novel mRNA vaccine candidate, HGCO19 has been developed by which of the following? Correct Answer Genova
The correct answer is Genova.
- India's first indigenous mRNA vaccine candidate has received approval from the Drug Controller General of India to initiate Phase I/II human clinical trial.
- mRNA-based vaccines are scientifically the ideal choice to address a pandemic because of their rapid developmental timeline
- The novel mRNA vaccine candidate, HGCO19 has been developed by Genova, a company based in Pune.
মোঃ আরিফুল ইসলাম
Feb 20, 2025